About

About Galenvs Sciences Galenvs couples precision magnetic-nanoparticle synthesis with advanced oligonucleotide chemistry— under ISO 9001 — to accelerate diagnostic, therapeutic product development. We engage projects from lead candidate optimization through rapid synthesis, purification, QA/QC, and pilot batches in weeks instead of months, and routinely supply complex siRNA, sgRNA, ASO, Aptamers, and other heavily modified oligos at ≥95 % yield. Our proprietary nanoparticles, tunable for size, coating, and functionality, deliver <1 % coefficient of variation, giving partners solid consistency for capture, purification, and targeted-delivery applications. Backed by six years of process data and AI-driven scale-up models, we offer flexible engagement— from OEM supply and white-label kits to full technology transfer with on-site start-up support— serving customers in human, veterinary, ag-bio, and environmental sectors across North America, Europe, and Asia-Pacific. Reach us at booth 1048.